OMB control number
The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study)
OMB 0910-0915 · HHS/FDA.
OMB 0910-0915
This proposed information collection supports the U.S. Food and Drug Administration’s (FDA) efforts to assess campaign effectiveness. The Center for Tobacco Products (CTP) is proposing to conduct a quantitative study of the effects of FDA’s The Real Cost campaign on youth in the U.S. The purpose of FDA’s The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 is to evaluate whether changes in key outcomes can be attributed to campaign exposure. We intend to measure self-reported campaign exposure to media advertising, which among many things, will enable FDA to assess its relationship with market-level delivery. The study will be conducted using web-based surveys that are self-administered on personal computers or web enabled mobile devices.
The latest form for The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study) expires 2026-08-31 and is listed under ICR 202312-0910-008.
Latest Forms, Documents, and Supporting Material
All Historical Document Collections
| Reference | Filing | Received | Concluded | Action |
|---|---|---|---|---|
| 202506-0910-001 | Revision of a currently approved collection | 2026-06-26 | ||
| 202410-0910-004 | No material or nonsubstantive change to a currently approved collection | 2024-10-18 | ||
| 202312-0910-008 | No material or nonsubstantive change to a currently approved collection | 2024-02-06 | Approved without change | |
| 202305-0910-001 | New collection (Request for a new OMB Control Number) | 2023-05-31 | Approved with change |
OMB Details
Recruitment Study Materials--Main: Baseline Recruitment & Follow-up 2 Replenishment
Federal Enterprise Architecture: Health - Consumer Health and Safety